ImmunoGen, Inc. Takes Over Top Spot Among Cancer Biotechs in the State

Published: Oct 18, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ImmunoGen Inc. has taken over the number one spot on the list of the state’s largest locally-owned cancer drug developers as ranked by market cap, but as CEO Dan Junius acknowledges, “it was an ugly way to get there.” The 32-year-old Waltham biotech was number two on the list until last week, when Ariad Pharmaceuticals saw a 75 percent stock crash following an FDA-mandated halt in enrollment in a late-stage trial of its sole product on the market - leukemia drug Iclusig - over safety concerns.

Help employers find you! Check out all the jobs and post your resume.

Back to news